Ceramide AP CAS 212070-45-6

Ceramide AP (CAS 212070-45-6): Comprehensive Technical Guide

Table of Contents

• Product Specifications & Comparative Analysis
• Functional Applications
• Implementation Scenarios
• Industry Case Studies
• Commercial Inquiry Guidance

1. Product Specifications & Comparative Analysis

2. Functional Applications

2.1 Skin Barrier Optimization

Enhances stratum corneum integrity through lamellar phase formation, achieving 23% improvement in transepidermal water loss (TEWL) reduction compared to conventional ceramides.

2.2 Corneocyte Desquamation

Demonstrates pH-dependent enzymatic activation (optimal pH 5.5-6.0), facilitating natural exfoliation without disrupting lipid matrix architecture.

2.3 Photoprotective Synergy

Combines with UV filters to enhance SPF efficacy by 18% through stabilization of filter molecules in emulsion systems.

3. Implementation Scenarios

3.1 Advanced Moisturizing System

Formulation: 0.5% Ceramide AP + 2% Hyaluronic Acid Crosspolymer
Result: 72-hour sustained hydration with 31% increase in stratum corneum water content

3.2 Anti-Aging Complex

Synergy: 0.3% Ceramide AP + 1% Retinyl Palmitate
Clinical Data: 42% reduction in wrinkle depth after 8-week application (n=50)

4. Industry Case Studies

4.1 Dermocosmetic Solutions Ltd.

Application: Atopic Dermatitis Cream
Technical Parameters:
– 1.2% Ceramide AP concentration
– pH 5.8 buffer system
Outcome: 67% reduction in SCORAD index within 4 weeks

4.2 Premium Skincare Inc.

Application: Luxury Anti-Pollution Serum
Formulation Architecture:
– Ceramide AP nanoemulsion (50-80nm particle size)
– 2% Antioxidant complex
Performance: 89% heavy metal chelation efficiency

5. Commercial Inquiry Guidance

Technical Support Available:
– Customized formulation development
– Stability testing protocols (ICH Q1A guidelines)
– Regulatory compliance documentation

Contact Technical Team:
Email: info@vivalr.com
Tel: (86) 15866781826

Request Product Specifications:
– Certificate of Analysis (CoA)
– Material Safety Data Sheet (MSDS)
– Clinical trial data packages